Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?"
about
Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?"
description
scientific article published on 01 February 2020
@en
name
Authors' Reply to Krebs-Brown ...... evothyroxine with an Old One?"
@en
type
label
Authors' Reply to Krebs-Brown ...... evothyroxine with an Old One?"
@en
prefLabel
Authors' Reply to Krebs-Brown ...... evothyroxine with an Old One?"
@en
P2093
P50
P1476
Authors' Reply to Krebs-Brown ...... evothyroxine with an Old One?"
@en
P2093
P304
P356
10.1007/S40262-019-00848-Z
P577
2020-02-01T00:00:00Z